202.08
price up icon0.60%   1.20
 
loading

Abbvie Inc Aktie (ABBV) Neueste Nachrichten

pulisher
Feb 21, 2025

Some May Be Optimistic About AbbVie's (NYSE:ABBV) Earnings - Yahoo Finance

Feb 21, 2025
pulisher
Feb 21, 2025

Parenteral Nutrition Market Future Business Opportunities - openPR

Feb 21, 2025
pulisher
Feb 20, 2025

AbbVie Inc. (ABBV) Stock: Pharmaceutical Sector Investment Option - INDODAX

Feb 20, 2025
pulisher
Feb 20, 2025

Antibody-Drug Conjugates Market to Witness Rapid Growth Across 7MM During the Study Period (2020–2034) as New Innovations Drive Therapy Advancements | DelveInsight - GlobeNewswire Inc.

Feb 20, 2025
pulisher
Feb 19, 2025

AbbVie Inc. (ABBV) Announces $4 Billion Senior Notes Offering - GuruFocus.com

Feb 19, 2025
pulisher
Feb 19, 2025

Real-World Evidence in IBD: Driving Innovative Approaches to Care - AbbVie

Feb 19, 2025
pulisher
Feb 18, 2025

AbbVie Stock Appears Ready To Move Higher (NYSE:ABBV) - Seeking Alpha

Feb 18, 2025
pulisher
Feb 18, 2025

Xilio Therapeutics’ $2.1 Billion Collaboration With AbbVie - Global Legal Chronicle

Feb 18, 2025
pulisher
Feb 18, 2025

Abbvie Inc. Reports 9.0 % Passive Stake In Xilio Therapeutics, Inc. As Of Feb 11SEC Filing - Marketscreener.com

Feb 18, 2025
pulisher
Feb 18, 2025

Is AbbVie Stock a Buy Now? - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

ABBV Quantitative Stock Analysis - Nasdaq

Feb 18, 2025
pulisher
Feb 18, 2025

Beyond the Possible: How AbbVie Uses Technology to Transform Medicines for Patients - CBS News

Feb 18, 2025
pulisher
Feb 17, 2025

How Is The Market Feeling About AbbVie? - Benzinga

Feb 17, 2025
pulisher
Feb 17, 2025

ABBV: 3 Dividend Growth Stocks for Long-Term Wealth - StockNews.com

Feb 17, 2025
pulisher
Feb 17, 2025

Aseptic Fill Finish Market Top Companies StudyAenova, AbbVie - openPR

Feb 17, 2025
pulisher
Feb 17, 2025

Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now - Insider Monkey

Feb 17, 2025
pulisher
Feb 16, 2025

10 Best Drug Stocks to Buy Now - Insider Monkey

Feb 16, 2025
pulisher
Feb 16, 2025

AbbVie Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance

Feb 16, 2025
pulisher
Feb 15, 2025

Focus Financial Network Inc. Trims Stake in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Roxbury Financial LLC Invests $496,000 in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

AbbVie Inc. (NYSE:ABBV) Shares Sold by Rhumbline Advisers - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

BXM Wealth LLC Takes Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Autumn Glory Partners LLC Lowers Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Blue Trust Inc. Buys 8,959 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

WealthPLAN Partners LLC Lowers Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Adell Harriman & Carpenter Inc. Buys 2,721 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

New Mexico Educational Retirement Board Reduces Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

AbbVie’s Next Chapter: A Beacon of Opportunity in Biopharma - Jomfruland.net

Feb 15, 2025
pulisher
Feb 15, 2025

AbbVie Inc. (NYSE:ABBV) Shares Sold by Vontobel Holding Ltd. - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Compound Global Advisors LLC Invests $311,000 in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

Robert Michael to succeed Gonzalez as Abbvie’s chair - BioCentury

Feb 14, 2025
pulisher
Feb 14, 2025

Kentucky Trust Co Purchases Shares of 7,089 AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Axecap Investments LLC Has $4.24 Million Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie Inc. (NYSE:ABBV) to Issue $1.64 Quarterly Dividend - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

7th Circ. Says Ex-AbbVie Worker Filed Race Bias Suit Too Late - Law360

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie (NYSE:ABBV) Trading Up 0.4%Still a Buy? - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie Inc. (ABBV) reports earnings - Quartz

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie Inc. SEC 10-K Report - TradingView

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie names CEO Robert Michael as board chair, Richard Gonzalez departs - MM+M Online

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie's new CEO tapped for board chairman - Crain's Chicago Business

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie: An Undervalued Dividend Aristocrat (NYSE:ABBV) - Seeking Alpha

Feb 14, 2025
pulisher
Feb 14, 2025

Correction to AbbVie Names CEO Robert Michael Chairman Article -February 14, 2025 at 09:52 am EST - Marketscreener.com

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie Lauds Michael as Chairman, CEO - Baystreet.ca

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie: CEO to become Chairman of the Board -February 14, 2025 at 09:24 am EST - Marketscreener.com

Feb 14, 2025
pulisher
Feb 14, 2025

Xilio (XLO) Stock Zooms 125% Higher On Cancer Fighting Deal with AbbVie - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie Just Paid Investors: Here's How Much They Received - 24/7 Wall St.

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie Names CEO Robert Michael as Board Chairman -February 14, 2025 at 07:59 am EST - Marketscreener.com

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie Appoints Robert A. Michael as Chairman - TipRanks

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie names Robert Michael as chairman of board of directors - TipRanks

Feb 14, 2025
pulisher
Feb 14, 2025

New York State Teachers Retirement System Has $283.57 Million Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Chevy Chase Trust Holdings LLC Has $170.82 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors - Yahoo Finance

Feb 14, 2025
pulisher
Feb 14, 2025

Abbvie Elects Robert A. Michael As Chairman -February 14, 2025 at 07:34 am EST - Marketscreener.com

Feb 14, 2025
pulisher
Feb 14, 2025

Kanawha Capital Management LLC Raises Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie and Xilio announce immunotherapy partnership worth over $2.1bn - PMLiVE

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie Inc. (NYSE:ABBV) Stock Position Trimmed by Supplemental Annuity Collective Trust of NJ - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Campbell Wealth Management Raises Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

1,976 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Asset Planning Inc - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie Inc. (NYSE:ABBV) Shares Sold by DT Investment Partners LLC - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Palacios Wealth Management LLC Acquires New Stake in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Arcus Capital Partners LLC Makes New Investment in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie Inc. (NYSE:ABBV) Shares Bought by Compagnie Lombard Odier SCmA - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

AbbVie Inc. (NYSE:ABBV) Shares Bought by Summit Trail Advisors LLC - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Attessa Capital LLC Acquires New Shares in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Polaris Capital Management LLC Cuts Stake in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Van ECK Associates Corp Buys 5,863 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Latitude Advisors LLC Increases Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

Mustang Bio sells assets and ends lease with AbbVie - Investing.com

Feb 13, 2025
pulisher
Feb 13, 2025

Mustang Bio Sells Assets to AbbVie, Transfers Lease - TipRanks

Feb 13, 2025
drug_manufacturers_general JNJ
$162.30
price up icon 1.64%
drug_manufacturers_general NVO
$88.08
price up icon 5.18%
drug_manufacturers_general MRK
$89.50
price up icon 2.08%
drug_manufacturers_general NVS
$109.35
price up icon 1.90%
$303.01
price up icon 1.71%
Kapitalisierung:     |  Volumen (24h):